Generated by AI
ICU Medical, Inc. is a medical technology company focused on infusion therapy, vascular access, and vital care products. ICU Medical develops, manufactures, and sells a broad portfolio that includes IV pumps, needlefree connectors, IV administration sets, sterile IV solutions, closed-system transfer devices for hazardous drugs, and safety software used in hospital and alternate care settings. The company also offers hemodynamic monitoring, respiratory, anesthesia, temperature management, and other critical care products that support clinical workflows and patient safety. Its product families are designed to help healthcare providers deliver medications and fluids, reduce contamination risks, and improve efficiency across the IV continuum of care. ICU Medical serves acute care hospitals, ambulatory clinics, and home or alternate-site care environments, making it an important supplier in medical devices and hospital infrastructure.
Website951 Calle Amanecer
San Clemente, CA, 92673
United States
The latest articles about ICUI.
ICU Medical (ICUI) is back in focus after third quarter results topped earnings and revenue expectations, driven by record Infusion Systems and Consumables sales and firmer adjusted profitability, with management reaffirming full year guidance near the upper end. Recent price action has picked up, with a 1-day share price return of 2.66%, a 7-day gain of 5.09%, and a 30-day rise of 10.31% taking ICU Medical to US$172.11. At the same time, a year-to-date share price return of 24.24% and a...
ICU Medical reported third quarter 2026 sales of US$560.44 million and net income of US$26.85 million, with basic earnings per share from continuing operations of US$1.07. Adjusted earnings and revenue exceeded analyst expectations, and the company reaffirmed its full year guidance. Stronger adjusted profitability, improved gross margin performance and debt reduction using robust free cash flow suggest ICU Medical is tightening its cost base while still funding product development and...
Summary of Aug 15's posts. Generated by AI.
No summary yet.
Summary of Aug 11's posts. Generated by AI.
ICU Medical Inc (ICUI) posted 5% organic revenue growth with record Infusion Systems and Consumables sales, while logistics consolidation weighed on Vital Care and tariff costs remained a headwind.
Summary of Sep 8's posts. Generated by AI.
Investors talking about ICUI also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.